Login
← Go Back
Parabolic Drugs
PARABDRUGS · Pharma > Pharmaceuticals & Drugs · MD: Pranav Gupta · Listing date: July 1, 2010
Stock Price vs Company Growth
3m
0.0%
6m
0.0%
1y
0.0%
5y
1.1%
10y
6.0%
all
14.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 5.5 0%
N/A
5.5
Company Overview
Sales
0 Cr
Growth: -2.5%
Profit after Tax
-20 Cr
Growth: -0.1%
Micro Cap
34 Cr
P/S: N/A
Industry P/S: 2.6x
Fundamentals
Sales (Cr) ₹ 0
Growth -2.5%
EBITDA N/A
P/S N/A
Dividend 0.0%
P/E -1.3x
Book Value ₹ -154
PEG Ratio 0.5x
ROE 2.1%
P/B N/A
Shareholding Pattern
Institutions
Apms Investment Fund Limited
3.42 %
Cresta Fund Ltd
3.03 %
Lotus Global Investment Limited
1.61 %
Promoters
Png Trading Private Limited
22.9 %
Parabolic Infrastructure Private Limited
10.32 %
Pranav Gupta
1.33 %
Vineet Gupta
1.13 %
Sachin Gupta
0.73 %
Others
Shyam Abhay Jasani
4.69 %
Exquisite Result International Limited
2.98 %
Anjani Yogeshbhai Sheth
1.17 %
Krishnakant Jayantilal Choksi
1.02 %
Increase    Decrease    No change
Company Profile Detailed
The company is presently engaged in the manufacturing, including contract manufacturing, of APIs and API intermediates for the domestic market as well as for exports to international markets, including regulated markets.Subsidiary of the company Parabolic Labs: The company was incorporated as a private limited company under the Companies Act, 1956 on November 21, 2007 and received its Certificate for Commencement of business on January 3, 2008.
Investors (17)
idbi.ban...
akrita.k...
sachin.g...